beating the analyst consensus estimate by a penny. The company reported quarterly sales of $267 million, missing the consensus estimate of $275.73 million. Monopar Therapeutics Inc. (NASDAQ: MNPR) …
More Mid-Day Market Update: Crude Oil Down Over 1%; Stealth BioTherapeutics Shares Plummet Videos